Display Settings:

Format

Send to:

Choose Destination
    Clin Exp Immunol. 2008 Feb;151(2):210-30.

    Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.

    Source

    Molecular Genetics and Rheumatology Section, Faculty of Medicine, Imperial College, Hammersmith Campus, London, UK. matthew.pickering@imperial.ac.uk

    Abstract

    Factor H is the major regulatory protein of the alternative pathway of complement activation. Abnormalities in factor H have been associated with renal disease, namely glomerulonephritis with C3 deposition including membranoproliferative glomerulonephritis (MPGN) and the atypical haemolytic uraemic syndrome (aHUS). Furthermore, a common factor H polymorphism has been identified as a risk factor for the development of age-related macular degeneration. These associations suggest that alternative pathway dysregulation is a common feature in the pathogenesis of these conditions. However, with respect to factor H-associated renal disease, it is now clear that distinct molecular defects in the protein underlie the pathogenesis of glomerulonephritis and HUS. In this paper we review the associations between human factor H dysfunction and renal disease and explore how observations in both spontaneous and engineered animal models of factor H dysfunction have contributed to our understanding of the pathogenesis of factor H-related renal disease.

    PMID:
    18190458
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2276951
    Free PMC Article

    Images from this publication.See all images (3) Free text

    Fig. 1
    Fig. 3
    Fig. 2

      Supplemental Content

      Icon for Blackwell Publishing Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk